LCM
MDGL icon

Landscape Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Landscape Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,456
Closed -$4.43M – 809
2026
Q1 		$4.43M Buy
8,456
+7,368
+677% +$3.52M 0.28% 107
2025
Q4 		$634K Buy
1,088
+78
+8% +$39.8K 0.04% 440
2025
Q3 		$463K Sell
1,010
-4,850
-83% -$1.81M 0.03% 472
2025
Q2 		$1.77M Sell
5,860
-847
-13% -$252K 0.14% 225
2025
Q1 		$2.22M Buy
6,707
+3,083
+85% +$1.01M 0.2% 168
2024
Q4 		$1.12M Buy
+3,624
New +$1.02M 0.12% 235

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Landscape Capital Management's MDGL Position: Q2 2026 in Review

Landscape Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 8,456 shares — an estimated $4.43M sold.

Landscape Capital Management first reported a position in MDGL in Q4 2024 and held it in 6 quarters. The position peaked at $4.43M in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Landscape Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 8,456 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $4.43M.
  • Landscape Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2024 and held it in 6 quarters.
  • Landscape Capital Management's Madrigal Pharmaceuticals position peaked at $4.43M in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.